Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glaukos (GKOS) Raw Materials (2016 - 2026)

Glaukos has reported Raw Materials over the past 13 years, most recently at $24.1 million for Q1 2026.

  • Quarterly Raw Materials rose 19.74% to $24.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $24.1 million through Mar 2026, up 19.74% year-over-year, with the annual reading at $25.4 million for FY2025, 31.22% up from the prior year.
  • Raw Materials was $24.1 million for Q1 2026 at Glaukos, down from $25.4 million in the prior quarter.
  • Over five years, Raw Materials peaked at $25.4 million in Q4 2025 and troughed at $9.2 million in Q1 2022.
  • The 5-year median for Raw Materials is $13.6 million (2023), against an average of $16.5 million.
  • Year-over-year, Raw Materials skyrocketed 88.84% in 2022 and then fell 8.73% in 2023.
  • A 5-year view of Raw Materials shows it stood at $13.6 million in 2022, then decreased by 8.73% to $12.4 million in 2023, then soared by 55.82% to $19.3 million in 2024, then soared by 31.22% to $25.4 million in 2025, then fell by 4.89% to $24.1 million in 2026.
  • Per Business Quant, the three most recent readings for GKOS's Raw Materials are $24.1 million (Q1 2026), $25.4 million (Q4 2025), and $24.5 million (Q3 2025).